Concurrent Presentations - NAPNAP

Concurrent Presentations

Concurrent Expert Presentations

Concurrent expert presentations are designed to offer innovative topics relevant to the equitable clinical pediatric health care of infants, children, adolescents and young adults, and advancing the APRN role. It is important that topics have strong clinical application, originality and are evidence based. Topics are needed to meet the learning needs of professionals in various stages of their careers, including those targeted towards students, early career NPs, seasoned NPs and NPs transitioning to new practice settings. Preference is given to novel topics that are supported by a strong needs assessment and learning formats that provide an engaging learning experience for participants.  

We welcome all session proposals and encourage those related to key topics frequently requested by past conference participants, including:

  • pharmacology, psychopharmacology, prescribing controlled substances
  • global health
  • health equity
  • topics crossing the care continuum, from primary to acute to specialty care
  • specialty care (including referral to specialty care and specialty focused billing and coding)
  • acute care and critical care
  • behavioral and mental health
  • leadership and professional issues (including NP Management, PNP education, child health advocacy)
  • innovative formats (including panel presentations, presentations incorporating the voices of interprofessional colleagues and patient families, and case studies)

Concurrent Expert Presentation Guidelines

Concurrent expert presentation proposals must represent a 60-75 minute individual presentation. Only the primary presenter will receive the speaker benefits. The online abstract submission application will request the following items:

1. Presentation title.

2. Abstract summary. Provide a summary, max 150 words, of the content of the proposed presentation. Describe the identified need using literature, anecdotal notes or other data.

3. Please describe what makes this presentation novel or distinguishes it from other similar and/or recent presentations. * Note: This is essential if your desired topic was presented at conference, whether by you/someone in your group, or others within the last five years.

4. Please provide the top three references to support evidence-based information in your abstract summary. 

5. Pediatric practice focus: * (Please select all that apply. )
1. Primary Care
2. Specialty Care
3. Acute Care
4. Critical Care
5. Academia
6. Nursing Research
7. Nursing Administration or Management (e.g. APRN Lead)
8. Diversity, Equity and Inclusion

6. Appropriate audience: (Please select all that apply.)
1. Student – Master or Doctoral level student who has not yet entered the NP workforce
2. Early Career – NP in the first few years of practice; Still learning APRN role and practice; Still developing competence & confidence
3. Seasoned – Established APRN practitioner
4. Role Transitioning – Seasoned NP in their current practice setting but considering a transition to a new area of practice or entering academia or research for the first time.

7. Please identify up to four key terms using (MeSH (Medical Subject Headings)). Visit to search for terms.

8. Include details of how you will incorporate participant interaction into the learning process, for example, ice breakers, questions and answers, small group discussion, audience response system.

9. Learning objectives. Please list 3-5 learning objectives. Please use verbs that reflect measurable behavioral objectives, such as Define, Identify, Recognize, Describe.

10. Included content: (Please select all that apply.)
1. Pharmacology
2. Psychopharmacology
3. Diversity, Equity and Inclusion
4. Controlled Substances
5. Class II medications
6. None of the above

11. Blinded biography. Primary Presenter Bio, max 250 words, highlighting educational background, professional experience, past presentations and published articles, especially those recent and relevant to this topic. Please note: this is a blinded review process. Names should be omitted from this section. Inclusion of applicant’s name may disqualify the abstract, or delay the submission process. 

12. Please indicate your highest level of presentation experience (Local – Level 1, State/regional – Level 2, National – Level 3, All of the above – Level 4) . 
1. Local audience
2. State/regional audience
3. National audience
4. All of the above
5. No experience

13.  Most appropriate for those with the following learning preferences: (Please select all that apply. Hold the shift key to select more than one response.)
1. Didactic/lecture learning formats (auditory learners with note-taking opportunity)
2. Hands-on learning formats (tactile learning)
3. Small Group learning formats (learn by collaborating)
4. Visual learning formats (learn by seeing, watching demonstrations)
5. Panel Discussions (learn by hearing different perspectives)

14. I understand that this abstract application process is very competitive, and if I am not selected for presentation at NAPNAP’s national conference, I would also like to be considered for: *
1. PedsCE Course
2. FaceBook Live Presentation
3. NAPNAP Town Hall Webinar Presentation
4. Intensive Workshop
5. Speed Session (5-15 minutes)
6. Future virtual conference presentation
7. I do not want to be considered for another format at this time.
8. Podcast
9. Other

Start your submission now. You’ll be forwarded to our abstract application system where you will need to enter your user ID /password to log in.

If you have any questions regarding the online abstract system, please contact Anna Chernis at [email protected].

Application Process: The Conference Planning Committee members evaluate the applications through a blinded peer-review process. The number of abstracts selected depends on the conference schedule and the number of time spaces allotted for the different types of presentations. The evaluation process takes place in early summer and presentation selection is usually completed by Sept. 15.

Powered by

Website design and development by, Inc.